Pharma Pulse
search-icon

Tag: antidepressant safety

Cough Suppressants and MAOIs: Dextromethorphan Interaction Risks

Cough Suppressants and MAOIs: Dextromethorphan Interaction Risks

Posted On March 30, 2026 0

Discover why combining dextromethorphan cough syrup with MAOI antidepressants can lead to life-threatening serotonin syndrome. Learn safe alternatives.

MOST POPULAR

Cost vs Benefit: When Expensive Medications Make Sense Despite Side Effects

Cost vs Benefit: When Expensive Medications Make Sense Despite Side Effects

Posted On December 16, 2025
Secondary Patents: How Pharmaceutical Brands Extend Market Exclusivity

Secondary Patents: How Pharmaceutical Brands Extend Market Exclusivity

Posted On February 5, 2026
Buspar for Anxiety: Benefits, Side Effects, How It Works, and Tips

Buspar for Anxiety: Benefits, Side Effects, How It Works, and Tips

Posted On June 12, 2025
Eczema & Tattoos: Safety Tips, Aftercare & What to Avoid

Eczema & Tattoos: Safety Tips, Aftercare & What to Avoid

Posted On October 15, 2025
PDE5 Inhibitors and Nitrates: Why Mixing Them Causes Dangerous Blood Pressure Drops

PDE5 Inhibitors and Nitrates: Why Mixing Them Causes Dangerous Blood Pressure Drops

Posted On June 23, 2026

Categories

  • Health (214)
  • Health Economics (18)

ARCHIVES

  • September 2026 (2)
  • August 2026 (12)
  • July 2026 (15)
  • June 2026 (12)
  • May 2026 (13)
  • April 2026 (7)
  • March 2026 (11)
  • February 2026 (11)
  • January 2026 (26)
  • December 2025 (29)
  • November 2025 (18)
  • October 2025 (30)
Pharma Pulse

Menu

  • About Pharma Pulse Weekly
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact Us

Recent Posts

Cost vs Benefit: When Expensive Medications Make Sense Despite Side Effects

Cost vs Benefit: When Expensive Medications Make Sense Despite Side Effects

Posted On December 16, 2025
Secondary Patents: How Pharmaceutical Brands Extend Market Exclusivity

Secondary Patents: How Pharmaceutical Brands Extend Market Exclusivity

Posted On February 5, 2026
© 2026. All rights reserved.